KIR3DS1 directs NK cell-mediated protection against human adenovirus infections
September 2021 | News
A recent study by Johannes Jung and colleagues in Science Immunology identifies the KIR3DS1/HLA-F axis as a new target for immunotherapeutic strategies against severe HAdV disease.
Martinistraße 52 Campus Research II N25 20246 Hamburg Germany This email address is being protected from spambots. You need JavaScript enabled to view it.